A genetic screen targeting the tumor necrosis factor/Eiger signaling pathway: identification of Drosophila TAB2 as a functionally conserved component by Geuking, Peter et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2005
A genetic screen targeting the tumor necrosis factor/Eiger signaling
pathway: identification of Drosophila TAB2 as a functionally conserved
component
Geuking, Peter; Narasimamurthy, Rajesh; Basler, Konrad
Abstract: Signaling by tumor necrosis factors (TNFs) plays a prominent role in mammalian development
and disease. To fully understand this complex signaling pathway it is important to identify all regulators
and transduction components. A single TNF family member, Eiger, is encoded in the Drosophila genome,
offering the possibility of applying genetic approaches for pursuing this goal. Here we present a screen
for the isolation of novel genes involved in the TNF/Eiger pathway. On the basis of Eiger’s ability
to potently activate Jun-N-terminal kinase (JNK) and trigger apoptosis, we used the Drosophila eye to
establish an assay for dominant suppressors of this activity. In a large-scale screen the Drosophila homolog
of TAB2/3 (dTAB2) was identified as an essential component of the Eiger-JNK pathway. Genetic epistasis
and biochemical protein-protein interaction assays assign an adaptor role to dTAB2, linking dTRAF1
to the JNKKK dTAK1, demonstrating a conserved mechanism of TNF signal transduction in mammals
and Drosophila. Thus, in contrast to morphogenetic processes, such as dorsal closure of the embryo, in
which the JNK pathway is activated by the JNKKK Slipper, Eiger uses the dTAB2-dTAK1 module to
induce JNK signaling activity.
DOI: 10.1534/genetics.105.045534
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-990
Originally published at:
Geuking, Peter; Narasimamurthy, Rajesh; Basler, Konrad (2005). A genetic screen targeting the tumor
necrosis factor/Eiger signaling pathway: identification of Drosophila TAB2 as a functionally conserved
component. Genetics, 171(4):1683-1694. DOI: 10.1534/genetics.105.045534
Copyright  2005 by the Genetics Society of America
DOI: 10.1534/genetics.105.045534
A Genetic Screen Targeting the Tumor Necrosis Factor/Eiger Signaling
Pathway: Identification of Drosophila TAB2 as a Functionally
Conserved Component
Peter Geuking, Rajesh Narasimamurthy and Konrad Basler1
Institut fu¨r Molekularbiologie, Universita¨t Zu¨rich, CH-8057 Zu¨rich, Switzerland
Manuscript received May 11, 2005
Accepted for publication July 22, 2005
ABSTRACT
Signaling by tumor necrosis factors (TNFs) plays a prominent role in mammalian development and
disease. To fully understand this complex signaling pathway it is important to identify all regulators and
transduction components. A single TNF family member, Eiger, is encoded in the Drosophila genome,
offering the possibility of applying genetic approaches for pursuing this goal. Here we present a screen for
the isolation of novel genes involved in the TNF/Eiger pathway. On the basis of Eiger’s ability to potently
activate Jun-N-terminal kinase (JNK) and trigger apoptosis, we used the Drosophila eye to establish an
assay for dominant suppressors of this activity. In a large-scale screen the Drosophila homolog of TAB2/3
(dTAB2) was identified as an essential component of the Eiger-JNK pathway. Genetic epistasis and bio-
chemical protein-protein interaction assays assign an adaptor role to dTAB2, linking dTRAF1 to the JNKKK
dTAK1, demonstrating a conserved mechanism of TNF signal transduction in mammals and Drosophila.
Thus, in contrast to morphogenetic processes, such as dorsal closure of the embryo, in which the JNK
pathway is activated by the JNKKK Slipper, Eiger uses the dTAB2-dTAK1 module to induce JNK signaling
activity.
LIGANDS of the tumor necrosis factor (TNF) familyregulate fundamental processes in humans, such
as apoptosis, cell survival, differentiation, proliferation,
and inflammation. Deregulation of TNF signaling path-
ways is associated with many diseases, including auto-
immune disorders and cancer. The study of TNF signaling
mechanisms in mammalian systems is complicated by
the existence of numerous ligands and receptors and at
least three different intracellular signaling pathways
(Wallach et al. 1999; Locksley et al. 2001). Recently
it became apparent that there is a single TNF ligand
(Eiger) encoded in the Drosophila genome (Igaki et al.
2002; Moreno et al. 2002; Kauppila et al. 2003), raising
the prospect of investigating conserved principles un-
derlying this signaling system by simple genetic means.
Like a subset of the mammalian TNF proteins, Eiger is
a potent inducer of apoptosis. Unlike its mammalian
counterparts, however, the apoptotic effect of Eiger
does not require the activity of the caspase-8 homolog
DREDD, but it completely depends on its ability to
activate the Jun-N-terminal kinase (JNK) pathway and
subsequent activation of the Drosophila apoptosome
(DARK1DRONC) (Moreno et al. 2002). Although the
JNK pathway is used multiple times in Drosophila de-
velopment, Eiger is the only known extracellular pro-
tein that triggers its activation. Of particular interest is
therefore the interface between the cell membrane and
the core JNK cassette [consisting of the JNKK Hemip-
terous (Hep), the JNK Basket (Bsk), and the transcrip-
tion factors Jun and Fos]. Apart from Wengen (Wgn),
the presumptive TNF receptor homolog in Drosophila
(Kanda et al. 2002; Kauppila et al. 2003), no other com-
ponents have been convincingly implicated in JNK ac-
tivation upstream of the candidate JNKKK dTAK1 (Vidal
et al. 2001).
Here we designed and performed a genetic screen
to isolate rate-limiting components in mediating Eiger-
induced apoptosis. We report the identification of.100
mutations that weaken the Eiger-JNK pathway. While
some of these mutations affect already known compo-
nents, such as Bsk and dTAK1, and thus validate the
screen, we further show that one group of alleles inac-
tivates a previously uncharacterized Drosophila gene,
CG7417. By genetic and biochemical means we demon-
strate that it functions as the TAB2/3 homolog. TAB2/3
have been demonstrated to link TNF receptor-associated
factor (TRAF) proteins to TAK1 in mammalian interleukin-
and TNF-signal transduction (Takaesu et al. 2000;
Ishitani et al. 2003). We propose that the Drosophila
TAB2/3 homolog provides, together with dTRAF1, an
adaptor function enabling the presumptive JNKKKK
Misshapen (Msn) to activate the JNKKK dTAK1, which
in turn advances the Eiger signal to the JNKK Hep and
its JNK substrate Bsk.
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MATERIALS AND METHODS
Fly stocks: The Bloomington Drosophila Stock Center
(BDSC) provided bsk1, Df(2R)P34, and the Exelixis deficiency
collection. The following reagents have been described pre-
viously: UAS-egr (Moreno et al. 2002), dTAK1 alleles and their
rescuing transgene (Vidal et al. 2001), UAS-hepCA (Adachi-
Yamada et al. 1999), and GMR-Gal4 (Hay et al. 1994).
Stocks carrying the UAS-Drosophila homolog of TAB2/3 (dTAB2)
and tubulina1-dTAB2 transgene were obtained by standard
P-element-induced transformation. The dTAB2 full-length cDNA
(LD40663) was cloned into pUAST (Brand and Perrimon
1993) or into a vector containing the tubulina1 promoter (Basler
and Struhl 1994), respectively.
EMS mutagenesis: Drosophila males carrying the GMR-Gal4
insertion were starved for 8 hr before mutagenesis. These
males were then kept for 24 hr in a bottle containing a filter
paper soaked with 0.4% EMS in sugar solution (1 g/100 ml).
After a recovery phase of another 24 hr on normal food, the
mutagenized males were mated at 25 with virgins carrying the
UAS-egr transgene.
Genetic distance to GMR-Gal4 insertion: Chromosomes
carrying the GMR-Gal4 insertion and a suppressor mutation
were allowed to recombine with a wild-type chromosome
in females. Such virgins were crossed to UAS-egr males. The
number of GMR-Gal4 progeny with a suppressed eye pheno-
type in relation to the number of GMR-Gal4 progeny with a
small eye phenotype reflects the genetic distance between the
suppressor mutation and the GMR-Gal4 insertion.
Generation and analysis of ey-flp mosaics: For genes that
did not dominantly suppress the Eiger-induced small eye
phenotype, such as djun and dTRAF1, ey-flp clones were
generated to obtain animals with eyes composed largely of
homozygous mutant cells (Newsome et al. 2000). In this
background the ability of Eiger to induce apoptosis was ana-
lyzed. Such analysis was uninformative, however, for the
dTRAF1ex1 allele (Cha et al. 2003) as mosaic eyes exhibited a
distorted pattern already in the absence of Eiger expression.
Sequencing: Genomic DNA was amplified by PCR using
evenly spaced primers in the CG7417, bsk, and dTAK1 coding
regions. PCR products were analyzed by standard sequencing.
Drosophila cell culture and transfection: Schneider (S2)
cells were cultured in Schneider’s Drosophila medium (In-
vitrogen, San Diego) supplemented with 10% fetal calf serum
and 1% penicillin/streptomysin at 25. Cells were transfected
with expression vectors, using Cellfectin (Invitrogen) accord-
ing to the manufacturer’s protocol.
Expression vectors: Full-length dTRAF1 and dTRAF2 coding
sequences were amplified by PCR, using ESTs RE63023 and
RE19938 as templates, respectively. These PCR fragments were
inserted into the triple-HA-containing vector pMZ55 and
subcloned into pUAST along with the 33 HA tag. The dTAK1-
FLAG construct was amplified by PCR from transgenic flies
harboring UAS-dTAK1 (gift from Makoto Nakamura) and
inserted into pUAST. FLAG-dTAB2, HA-dTAB2-N, HA-dTAB2-C,
and HA-dTAB2-Dcc were amplified by PCR from a HA-dTAB2
construct and cloned into pUAST. The UAS-Wengen plasmid
was a gift from E. Moreno.
Immunoprecipitation and immunoblotting: S2 cells (0.753
106 cells/well) were seeded into a 12-well plate. One day after
seeding cells were transfected with the indicated expression
vectors. Forty-eight hours after transfection the cells were
harvested and lysed in lysis buffer containing 150 mm NaCl,
50 mm Tris-HCl (pH 8.0), 1% Nonidet P-40, 0.5% deoxy-
cholic acid, and protease inhibitors (Complete Mini; Roche,
Indianapolis). Lysates were mixed either with an anti-HA
antibody and 25 ml of Protein-A sepharose beads or with 25 ml
of anti-FLAG agarose beads (Sigma, St. Louis) and allowed to
rotate at 4 overnight. The beads were then collected and
washed with the lysis buffer four times. Proteins were eluted
from the beads and resolved on a 4–12% NUPAGE gel system
(Invitrogen) and transferred to a nitrocellulose membrane.
After blocking, the membrane was incubated with either
anti-HA antibody (3F10, Roche) or anti-FLAG M2 antibody
(Sigma) followed by appropriate secondary antibodies conju-
gated with horseradish peroxidase (HRP). Signals were de-
tected with ECL reagents (Amersham, Arlington Heights, IL).
Double-stranded RNA production: Double-stranded RNA
(dsRNA) was prepared as described by the Dixon lab (Clemens
et al. 2000). Briefly, using PCR products as templates, the
MEGASCRIPT T7 transcription kit (Ambion, Austin, TX) was
used to produce RNA according to the manufacturer’s protocol.
RNA products were ethanol precipitated and resuspended in
DEPC-treated water. dsRNA was generated by annealing at 65
for 30 min followed by slow cooling to room temperature. The
following sets of forward (FP) and reverse primers (RP) were
used: Basket (FP 59 cgccgcaaaggaacttgg 39; RP 59 tcagcatcatac
cacacg 39), dTAK1 (FP 59 gatgaccaacaatcgcgg 39; RP 59 ggcgct
gagtggcctcagc 39), msn (FP 59 atggcgcaccagcagcaacaac 39; RP 59
ccatctccagagcggtgatgc 39), and dTAB2 (FP 59 atggcggctacaccac
caatgc-39; RP 59 gtcgctgctggcgctgcataatc 39).
LPS treatment: S2 cells were treated with dsRNA (15mg/106
cells) as indicated in Figure 5F. The cells were then split into
two. One-half was left untreated and one-half was treated with
lipopolysaccharide (LPS) (Sigma) at a concentration of 50mg/ml
for 10 min. The cells were then lysed in lysis buffer. The lysates
were analyzed by immunoblotting to detect phosphorylated
JNK (Promega, Madison, WI) and JNK (Santa Cruz Biotech-
nologies, Santa Cruz, CA).
Luciferase assay: S2 cells (0.43 106 cells/well) were seeded
into a 24-well plate. One day after seeding cells were trans-
fected with an AP1-luciferase reporter plasmid along with the
indicated expression vector. The total DNA concentration
(1 mg) was kept constant by supplementing with empty vector.
Forty-eight hours after transfection, cells were harvested, lysed
in passive lysis buffer, and luciferase activity was measured
using the dual luciferase assay system (Promega). The values
shown reflect the relative luciferase activity: the ratio of firefly
(AP1 luciferase) and tub-renilla luciferase activity of one rep-
resentative experiment in which each transfection was made in
duplicate.
RESULTS
A dominant modifier screen to identify new compo-
nents of the Eiger-JNK pathway: Forced expression of
Eiger in the developing compound eye of Drosophila
triggers massive apoptosis and results in a small eye
phenotype (Figure 1, A and B; Igaki et al. 2002; Moreno
et al. 2002; Kauppila et al. 2003). A reduction in copy
number of genes encoding core JNK pathway compo-
nents partially rescues this phenotype (Figure 1C; Igaki
et al. 2002; Moreno et al. 2002). Complete elimination
of bsk (encoding Drosophila JNK) or djun in mosaic an-
imals by genetic means or suppression of Bsk activity by
forced expression of the JNK-phosphatase Puckered
(Martin-Blanco et al. 1998) reverted the Eiger-induced
small eye phenotype (data not shown and Moreno et al.
2002). Hence, all apoptosis-inducing activity of the
Eiger pathway is apparently transduced by the JNK
pathway (Figure 1E). Animals heterozygous for dTAK1
dominant-negative alleles (Figure 1D) or hemizygous
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mutant for dTAK1 (null allele, Figure 4F) also show a
complete suppression of the small eye phenotype. Thus
dTAK1 appears to provide the most relevant JNKKK
function in the Eiger pathway, as none of the other five
putative JNKKK homologs encoded in the Drosophila
genome (Stronach 2005) can substitute for dTAK1.
Indeed, removing one copy of slipper, which codes for
a JNKKK involved in JNK activation during the mor-
phogenetic process of dorsal closure (Stronach and
Perrimon 2002), does not suppress the small eye phe-
notype (data not shown).
The above described assay was used as a basis for a
screening system to identify genes required for Eiger
signaling. Adult males carrying a GMR-Gal4 transgene
were mutagenized with EMS and mated to UAS-eiger
females (UAS-egr ; see crossing scheme in Figure 2A). The
progeny was scored for suppression of the small eye phe-
notype. Candidate suppressors were isolated, retested,
and mapped to individual chromosomes by virtue of
visible markers on chromosomes 2 and 3 (Figure 2A).
After screening 55,000 animals, 117 stocks with sup-
pressor mutations were established (Figure 2B), each
categorized in one of three phenotypic classes on the
basis of the extent of the rescue: ‘‘complete’’ (not shown),
‘‘intermediate’’ (Figure 2C), and ‘‘weak’’ (Figure 2D).
Validation of the screen: In our screen, the genome
of GMR-Gal4 animals was exposed to the EMS mutagen.
Since Gal4 activity is vital for the small eye phenotype,
we expected some of the suppressors to harbor muta-
tions in the Gal4 driver transgene. Twenty-one such events
were indeed identified on the basis of the following
criteria: (i) lack of recombination separating the sup-
pressor mutation and the GMR-Gal4 transgene insertion
and (ii) suppression of unrelated Gal4-dependent over-
expression phenotypes, such as the UAS-Inr-driven big
eye phenotype (Brogiolo et al. 2001). Most members of
this class show a full reversion of the Eiger-induced small
eye phenotype and thus accounted for the vast majority
of the complete suppressors.
As described above, JNK activity is critical for the
transduction of the Eiger signal. One prediction for our
screen would therefore be that it leads to the isolation of
new basket (bsk) alleles (Figure 2E). All suppressor muta-
tions that mapped to the second chromosome were
subjected to a complementation analysis with a pre-
viously described allele of bsk (Riesgo-Escovar et al.
1996; Sluss et al. 1996). Ten mutations failed to com-
plement bsk1 and subsequent sequence analysis revealed
that all of them carry molecular lesions in the bsk coding
region (Figure 2J, Table 1).
Only one mutation (G14) mapped to the X chromo-
some (Figure 2F). This mutation is homozygous viable
and completely suppresses the Eiger-induced small eye
phenotype when hemizygous (not shown). Since this
behavior reflects exactly that of known dTAK1 alleles
(Figure 4F), we expected, and also found, a mutation in
the dTAK1 coding region of G14. To confirm that the
detected mutation (Thr221/ Iso) is indeed responsi-
ble for the observed suppression of Eiger signaling,
rescue experiments with a genomic dTAK1 transgene
were performed (Vidal et al. 2001). G14 animals car-
rying the dTAK1 rescue construct displayed a reduced
suppression of the small eye phenotype (Figure 2G).
The known dTAK1 allele dTAK14 shows the same behav-
ior (Figure 2H, compare with Figure 1D). The pre-
sumed dominant-negative nature of these two dTAK1
alleles (4 and G14) may explain why the eye phenotype
is not completely reverted to ‘‘small.’’ Indeed, the sup-
pression activity of a presumed null allele of dTAK1 is
fully inhibited by the dTAK1 transgene rescue construct
Figure 1.—The small eye phenotype
caused by eiger (egr) overexpression in the eye
provides a sensitized system to screen for
new components. (A) GMR-Gal4 UAS-egr/1.
Overexpression of egr in the Drosophila com-
pound eye leads to a small eye phenotype
due to massive induction of apoptosis. (B)
GMR-Gal4/1 control eye. (C) GMR-Gal4
UAS-egr/bsk1. Removing a single copy of
the Drosophila JNK gene bsk dominantly
suppresses the small eye phenotype. (D)
dTAK14/1 ; GMR-Gal4 UAS-egr/1. dTAK14
is a dominant-negative allele of dTAK1,
which fully suppresses the small eye pheno-
type in a dominant fashion. (E) Schematic
representation of the current model of Eiger
signaling.
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(Figure 4G), while an unrelated suppressor mutation
(G56) from our screen showed the same extent of
suppression irrespective of the presence or absence of
the dTAK1 rescue construct (Figure 2I, compare with
Figure 2C).
Mapping and molecular cloning of a novel Eiger
suppressor: Complementation analysis revealed that,
with the exception of our bsk alleles and one thus far
uncharacterized complementation group, most of the
mutations isolated in our screen are homozygous viable
like mutations in the dTAK1 or eiger (egr) genes (Vidal
et al. 2001; Igaki et al. 2002). To group our second chro-
mosomal suppressors by other means, we mapped them
by recombination analysis relative to the GMR-Gal4
insertion (see materials and methods). In parallel, we
screened a large collection of deficiencies for dominant
suppressors of the Eiger-induced small eye phenotype.
These deficiencies are molecularly mapped and un-
cover 56% of the Drosophila genome (Parks et al.
2004). Interestingly, one group of our EMS-induced mu-
tations mapped to the same chromosomal region as de-
ficiency Df(2R)Exel6069, which behaved as a suppressor
Figure 2.—A dominant modi-
fier screen to identify new compo-
nents of the Eiger pathway in
Drosophila. (A) Crossing scheme.
Males carrying a GMR-Gal4 trans-
gene are mutagenized with EMS
and crossed to virgins carrying
a UAS-egr transgene. Suppressors
were rescreened, balanced, and
mapped to a chromosome by virtue
of visible dominant markers. The
second chromosome is marked by
the w1 (dark red) included in
the GMR-Gal4 insertion. The w1
of the UAS-egr insertion displays
an orange eye color. The third
chromosome is marked by the ab-
sence of a P[y1] insertion present
on the non-EMS-treated chromo-
some. Lethal mutations on the X
chromosome escaped our detect-
ing system. Since the X chromo-
some was not marked, viable
mutations, which were obtained
only when female suppressors were
selected, could not be followed and
therefore were obtained only rarely.
(B) Numbers of animals that were
screened and rescreened and
stocks that were established, with
the number of alleles identified
for positive controls. C–I are in a
GMR-Gal4 UAS-egr/1 background.
(C) GMR-Gal4 UAS-egr/G56. An ex-
ample of a suppressor belonging to
the ‘‘intermediate’’ class is shown.
(D) GMR-Gal4 UAS-egr/G87. An ex-
ample of a suppressor belonging
to the ‘‘weak’’ class is shown. (E)
GMR-Gal4 UAS-egr/bskG258. G258,
one of the new bsk alleles identified
in the screen, dominantly sup-
presses the small eye phenotype.
(F) dTAK1G14/1; GMR-Gal4 UAS-
egr/1. G14, the dTAK1 allele identi-
fied in the screen, dominantly
suppresses the small eye phenotype.
(G) dTAK1G14/1; GMR-Gal4 UAS-egr ; P(dTAK1)/1. (H) dTAK14/1; GMR-Gal4 UAS-egr/1; P(dTAK1)/1. (I) GMR-Gal4 UAS-egr/G56;
P(dTAK1)/1. A dTAK1 genomic rescue transgene partially reverts the suppression of the small eye phenotype caused by heterozygous
loss of dTAK1G14 or dTAK14 but not the suppression caused by the unrelated suppressor mutation G56. The suppression of the small eye
phenotype is not completely reverted by the dTAK1 rescue construct due to the dominant-negative nature of the dTAK1G14 and dTAK14
alleles. Both carry amino acid substitutions in the kinase domain of dTAK1 (Vidal et al. 2001), which leads to dominant-negative pro-
teins. (J) Molecular lesions found in the 10 novel bsk mutants.
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of Eiger signaling (Figure 3B). Df(2R)Exel6069 uncovers
only 20 genes at cytological position 56B5–56C11. By
using overlapping deficiencies and sequence analysis
(Figure 3A), we identified in 39 suppressors molecular
lesions in gene CG7417 (Figure 3C, Table 2). We inter-
preted these results as an indication that CG7417 may en-
code a component critically required for Eiger signaling.
CG7417 encodes the Drosophila homolog of TAB2:
The full open reading frame (represented by cDNA
LD40663) of CG7417 encoded an uncharacterized pro-
tein of 831 amino acids with a CUE, a coiled-coil, and
a zinc-finger domain (Figure 3C). These domains are
found together only in human TAB2 and TAB3 and in
homologs of these proteins in other organisms. Human
TAB2 and TAB3 are almost identical and were identi-
fied as binding partners of TAK1 (Takaesu et al. 2000;
Ishitani et al. 2003; Cheung et al. 2004; Jin et al. 2004).
On the basis of the conserved domain architecture we
propose CG7417 as the Drosophila homolog of TAB2
and TAB3 and hereafter refer to CG7417 as dTAB2.
Each of the 39 dTAB2 alleles displays a similar degree
of suppression of the Eiger-induced small eye pheno-
type (Figure 4A). Removing both copies of dTAB2 does
not fully revert the small eye phenotype to wild type
(Figure 4B), indicating that even in complete absence of
dTAB2 a slight activation of the pathway can occur (see
discussion). To verify that the suppression activity of
our alleles is indeed caused by the mutations detected in
TABLE 1
Molecular lesions identified in basket (bsk)
Allele DNA level Protein level
G418 39 splice site intron 3 AG/AA —
G368 CAG/TAG Gln115/Stop
G179 (independent of G536) TCC/TTC Ser127/Phe
G536 (independent of G179) TCC/TTC Ser127/Phe
G577 GCA/GTA Ala143/Val
G400 ACC/ATC Thr181/Ile
G760 CCC/TCC Pro182/Ser
G290 TCC/TTC Ser208/Phe
G258 TGG/TGA Trp232/Stop
G688 CGG/CCG Arg308/Pro
Alleles are ordered according to their position in the protein. Nucleotide changes are in bold face type. In a
GMR-Gal4 UAS-egr background, all alleles display an ‘‘intermediate’’ strength of suppression.
Figure 3.—Identification of dTAB2 (CG7417). (A) The two overlapping deficiencies Df(2R)Exel6069 and Df(2R)P34 narrow down
the region of interest to 11 genes. The distal breakpoint of Df(2R)P34 was placed between CG11906 and ribbon on the basis of the
fact that Df(2R)P34 and ribbon fail to complement each other (Bradley and Andrew 2001). The CG7417 coding region has a
mutation in 39 of the established suppressor stocks. (B) GMR-Gal4 UAS-egr/Df(2R)Exel6069. Df(2R)Exel6069 dominantly suppresses
the small eye phenotype whereas Df(2R)P34 does not. (C) Domain architecture and mutations identified in the dTAB2 protein.
Red, Gln/ Stop. Blue, Arg/ Stop. Green, Trp/ Stop. Gold, deletions. Black, splice sites mutated. Gray, amino acid substitutions.
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the dTAB2 coding region, rescue experiments with a
tubulina1 promoter-driven dTAB2 transgene were car-
ried out. The predicted suppression caused by hetero-
zygosity for dTAB2 could be overcome by expression of a
tubulina1-dTAB2 transgene (Figure 4C). Importantly,
the tubulina1-dTAB2 construct had no effect on the sup-
pression of the Eiger eye phenotype brought about by
an unrelated suppressor mutation (G56, Figure 4D).
dTAB2 functions upstream of Hep and dTAK1: Ex-
pression of a constitutively active form of Hep (hepCA)
(Adachi-Yamada et al. 1999) causes a reduction in eye
size (Figure 4H). This effect is mediated by JNK activa-
tion as it is completely inhibited by coexpression of Puc
(not shown). The HepCA small eye phenotype is sup-
pressed by reducing bsk activity (Figure 4I), but not by
reducing dTAB2 activity (Figure 4J), indicating that Bsk
and dTAB2 act downstream and upstream of Hep,
respectively. The HepCA phenotype is not suppressed in
males hemizygous for dTAK1, placing dTAK1, like dTAB2,
upstream of Hep (not shown). To address where dTAB2
and dTAK1 act relative to each other, epistasis experi-
ments were performed in S2 cells, using a JNK luciferase
TABLE 2
Molecular lesions identified in dTAB2 (CG7417)
Allele DNA level Protein level
G71 CAG/TAG Gln40/Stop
G576 CAG/TAG Gln66/Stop
G973 CAG/TAG Gln107/Stop
G58 CAA/TAA Gln119/Stop
G635 CGA/TGA Arg209/Stop
G609 CAA/TAA Gln216/Stop
G421 CAG/TAG Gln224/Stop
G867 CGA/TGA Arg233/Stop
G503 (independent of G585) CAA/TAA Gln317/Stop
G585 (independent of G503) CAA/TAA Gln317/Stop
G683 CAG/TAG Gln330/Stop
G245 7-bp Del bp 1203–1209 of CDS Premature Stop at AA422
G666 CAG/TAG Gln458/Stop
G552 (independent of G734) CAG/TAG Gln486/Stop
G734 (independent of G552) CAG/TAG Gln486/Stop
G642 59 splice site intron 2 GT/GA —
G788 CAG/TAG Gln542/Stop
G253 CAG/TAG Gln544/Stop
G981 CTG/CAG1GAC/AAC Leu570/Gln1Asp592/Asn
G539 284-bp Del bp 1711–1994 of CDS 1
CA insertion at breakpoint/
in frame!
Thr571/His, Glu572/Gln,
AA 573–666 deleted
G275 AGA/TGA Arg581/Stop
G933 39 splice site intron 3 AG/AA —
G746 CAA/TAA Gln633/Stop
G489 CAG/TAG Gln634/Stop
G548 CAG/TAG Gln641/Stop
G954 CAG/TAG Gln689/Stop
G545 CAG/TAG Gln712/Stop
G227 CAG/TAG Gln713/Stop
G812 CAG/TAG Gln720/Stop
G271 CAG/TAG Gln728/Stop
G829 CAG/TAG Gln731/Stop
G603 CAG/TAG Gln744/Stop
G520 (independent of G715) TGG/TAG Trp767/Stop
G715 (independent of G520) TGG/TAG Trp767/Stop
G701 (independent of G824) TGG/TGA Trp767/Stop
G824 (independent of G701) TGG/TGA Trp767/Stop
G211 TGC/GGC1AAC/AAA Cys769/Gly1Asn770/Cys
G928 GGT/GAT Gly794/Asp
G825 53-bp Del bp 2437–2489 of CDS Frameshift leads to a longer
protein
Alleles are ordered according to their position in the protein. Nucleotide changes are in boldface type. In a
GMR-Gal4 UAS-egr background, all alleles display an ‘‘intermediate’’ strength of suppression.
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reporter system in combination with RNAi. Expression
of dTAK1 strongly activated a JNK luciferase reporter.
Reporter activity was reduced by RNAi against bsk (Figure
4K) or djun (not shown), but not by RNAi against msn or
dTAB2 (Figure 4K), although RNAi against msn and
dTAB2 strongly reduces their protein levels (data not
shown). These experiments place Msn and dTAB2 up-
stream of dTAK1.
dTAB2 links dTRAF1 to dTAK1: In contrast to HepCA
and dTak1, overexpression of dTAB2—either in S2 cells
Figure 4.—dTAB2 functions upstream of Hep and dTAK1. A–G are in GMR-Gal4 UAS-egr/1 background. (A) GMR-Gal4 UAS-
egr/dTAB2G609. dTAB2 alleles dominantly suppress the small eye phenotype. (B) GMR-Gal4 UAS-egr dTAB2G609/dTAB2G71. The small
eye phenotype is not completely suppressed in dTAB2 homozygous mutant flies. (C) GMR-Gal4 UAS-egr/dTAB2G609; tub-dTAB2. (D)
GMR-Gal4 UAS-egr/G56; tub-dTAB2. A tub-dTAB2 rescue transgene reverts the suppression of the small eye phenotype caused by
heterozygous loss of dTAB2, but not the suppression brought about by the unrelated suppressor mutation G56. (E) GMR-Gal4 UAS-
egr/UAS-dTAB2. Overexpression of wild-type dTAB2 has a dominant-negative effect on Eiger signal transduction. (F) dTAK12/Y;
GMR-Gal4 UAS-egr/1. A hemizygous null allele of dTAK1 completely suppresses the small eye phenotype. dTAK12 has an early stop
mutation (Vidal et al. 2001). (G) dTAK12/Y; GMR-Gal4 UAS-egr/1; P(dTAK1)/1. In contrast to dominant-negative alleles of dTAK1
(G14, 4), the suppression of the small eye phenotype brought about by a null allele of dTAK1 can be completely reverted by in-
troducing a dTAK1 genomic rescue transgene. (H) GMR-Gal4 UAS-hepCA/1. (I) GMR-Gal4 UAS-hepCA/bskG258. ( J) GMR-Gal4 UAS-
hepCA/dTAB2G71. The small eye phenotype caused by overexpression of a constitutive active form of Hep is dominantly suppressed
by removing one copy of bsk but not by removing one copy of dTAB2. (K) RNAi against bsk but not against msn or dTAB2 suppresses
the dTAK1-FLAG-induced activation of the AP1-luc-reporter in S2 cells. (L) Overexpression of UAS-HA-dTAB2 does not activate
the AP1-luc-reporter. Wild-type dTAB2 does not exert a dominant-negative effect on dTAK1-mediated activation of the JNK path-
way. Numbers in parentheses indicate amounts of plasmid in micrograms.
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(Figure 4L) or in vivo (not shown)—does not activate
the JNK pathway, indicating that dTAB2 does not func-
tion as a direct activator of dTAK1 but possibly provides
an adaptor function. Consistent with this notion, we find
that overexpression of dTAB2 exerts a dominant-negative
effect on Eiger signal transduction, as it suppresses the
Eiger-induced small eye phenotype (Figure 4E).
To explore the molecular nature of such an adaptor
function we carried out protein-protein interaction
assays with candidate partners of dTAB2. We first found
that N-terminally HA-tagged dTAB2 can immunopre-
cipitate C-terminally FLAG-tagged dTAK1 from Dro-
sophila S2 cell lysates, and vice versa (Figure 5A). The
N-terminal half of dTAB2 (aa 1–450), which includes
the CUE domain, did not bind to dTAK1, but the
C-terminal half (aa 451–831), which includes coiled-coil
and Zn-finger domains, was sufficient to interact with
dTAK1 (Figure 5B). Removal of amino acids 451–749
severely impaired its interaction with dTAK1 (Figure
5B). This indicates that dTAB2, like TAB2/3 in mam-
malian systems, interacts with dTAK1 most likely through
its coiled-coil domain.
On the basis of the proximal placement of dTAB2 in
the Eiger pathway (see above), we also analyzed its in-
teraction with the Drosophila homologs of the TRAF
proteins. FLAG-dTAB2 was coexpressed either with an
HA-dTRAF1 or with HA-dTRAF2 in S2 cells and was
immunoprecipitated with an anti-HA antibody. Western
blot analysis of the immune complexes with an anti-
FLAG antibody revealed that dTRAF1 (the homolog of
hTRAF2) and dTRAF2 (the homolog of hTRAF6) pre-
cipitated dTAB2 (Figure 5C). The weaker binding of
dTAB2 to dTRAF1 compared to dTRAF2 might be ex-
plained by the lack of a RING-finger domain in dTRAF1.
The interaction of TAB2/3 with TRAF2/6 in mammals
is dependent in part on ubiquitination, which is mediated
by the ring-finger domain (Takaesuet al. 2000; Ishitani
et al. 2003; Kanayama et al. 2004). The intact ZnF
domain of TAB2/3 is required for binding to polyubi-
quitin chains (Kanayama et al. 2004).
We also tested the binding of the presumptive Eiger
receptor Wengen for its interaction with Drosophila
TRAF proteins. Wengen was expressed with either HA-
dTRAF1 or HA-dTRAF2 in S2 cells. The dTRAFs were
precipitated with anti-HA and the precipitates were
analyzed with an anti-Wengen antibody (Figure 5D). In
agreement with the result of Kauppila et al. (2003) we
found that Wengen can interact with dTRAF2. In addi-
tion, we find that Wengen also interacts with dTRAF1
(Figure 5D).
Next, we asked whether dTRAF1 interacts with dTAK1
directly or via dTAB2. S2 cells were cotransfected with
dTAK1-FLAG and either HA-dTRAF1 or HA-dTRAF2.
We could detect a very weak binding of both TRAFs with
dTAK1, perhaps mediated by endogenous dTAB2.
Upon coexpression of dTAB2, significantly increased
amount of dTAK1 was precipitated (Figure 5E). This
result suggests that dTAB2 can act as an adaptor mole-
cule to link dTRAFs to dTAK1.
dTAB2 mediates JNK activation also upon LPS
stimulation: LPS-induced JNK phosphorylation reflects
JNK activation during an innate immune response
(Sluss et al. 1996; Boutros et al. 2002). Treatment of
S2 cells with LPS indeed dramatically increases JNK
phosphorylation (Figure 4F). RNAi targeting dTAK1 or
dTAB2 (Figure 4F), but not eiger, wengen, or msn (not
shown), prevents this increase in JNK phosphorylation.
From this we conclude that dTAB2 mediates dTAK1
activation not only in the Eiger pathway but also in re-
sponse to other stimuli. Furthermore these results sug-
gest that dTAB2, like dTAK1 (Vidal et al. 2001), may also
play an important role in innate immunity.
DISCUSSION
Here we describe an effective genetic modifier screen
for the identification of components of the primordial
TNF-JNK-pathway in Drosophila. The isolation of muta-
tions in bsk and dTAK1 validated the specificity of the
screen. In addition, the identification of dTAB2 alleles
demonstrates that this screening system will also lead to
the discovery of other novel components, which so far
have escaped detection by genetic means. Together with
the low redundancy of its genome, our findings indicate
that Drosophila serves as a suitable system to genetically
dissect the TNF pathway. Identification of new evolu-
tionarily conserved components of the TNF pathway may
shed light on as-yet unknown aspects of this signaling
system that plays numerous roles in human disease.
The screen: The high number of alleles identified for
bsk and dTAB2 suggests that we have reached saturation
for dosage-sensitive components, at least for the second
and third chromosome. The allele frequencies for the
loci analyzed differ considerably. The fact that we found
only a single dTAK1 allele can be explained by the ge-
netic setup, in which only a small fraction of mutagen-
ized X chromosomes are recovered (see Figure 2A
legend). While the allele frequencies for the bsk and
Gal4 genes are roughly proportional to the size of their
coding regions (bsk, 1 kb—10 alleles; Gal4, 2.6 kb—21
alleles), we isolated a surprisingly high number of
dTAB2 alleles (the dTAB2 coding region is2.5 kb, with
39 molecularly confirmed alleles). This high number of
dTAB2 alleles is particularly surprising when the low
degree of sequence conservation is taken into consid-
eration. Only short domains with sequence similarities
to its mammalian homologs can be identified (Figure
3C: CUE, coiled coil, and ZnF), consistent with a role as
an adaptor protein. The most effective way to abolish
the function of an adaptor is to disconnect the two
protein interaction domains, which genetically is best
achieved by the introduction of a stop codon between
these domains. EMS induces primarily G/C / A/T
mutations (Ashburner 1989). Codons of only three
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Figure 5.—dTAB2 is in a complex with dTRAF1/2 and dTAK1. (A) dTAB2 interacts with dTAK1. S2 cells were transfected with
plasmids encoding UAS-HA-dTAB2 and UAS-dTAK1-FLAG together with ptub-GAL4. Samples that immunoprecipitated with anti-
FLAG antibody were immunoblotted with anti-HA antibody and vice versa. (B) dTAB2 interacts with dTAK1 most likely through its
coiled-coil domain. S2 cells were transfected with plasmids encoding UAS-dTAK1-FLAG and UAS-HA-dTAB2 or UAS-HA-dTAB2-N or
UAS-HA-dTAB2-C or UAS-HA-dTAB2-Dcc together with ptub-GAL4. Anti-FLAG immunoprecipitated samples were immunoblotted
with anti-HA antibody or vice versa. (C) dTAB2 associates with both dTRAF1 and dTRAF2. S2 cells were transfected with plasmids
encoding UAS-FLAG-dTAB2 and UAS-HA-dTRAF1 or UAS-HA-dTRAF2 together with ptub-GAL4. Samples immunoprecipitated with
the anti-HA antibody were detected with anti-FLAG antibody. (D) The presumptive Eiger receptor Wengen interacts with both
dTRAF1 and dTRAF2. S2 cells were transfected with plasmids encoding Wengen and UAS-HA-dTRAF1 or UAS-HA-dTRAF2 together
with ptub-GAL4. Anti-HA antibody immunoprecipitated samples were immunoblotted with an anti-Wengen antibody. (E) dTAB2
links dTRAF1 and dTRAF2 to dTAK1 and forms a triple complex. S2 cells were transfected with plasmids encoding UAS-FLAG-
dTAB2, UAS-dTAK1-FLAG, and UAS-HA-dTRAF1 or UAS-HA-dTRAF2 together with ptub-GAL4. Anti-HA antibody-immunoprecipitated
samples were immunoblotted with anti-FLAG antibody. (C–E) Asterisks (*) indicate nonspecific bands in the HA-dTRAF2 lysates.
(F) dTAB2 is also required for LPS-induced JNK activation. RNAi against dTAK1 or dTAB2 but not against GFP abolishes LPS-
mediated phosphorylation of JNK in S2 cells.
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amino acids can be mutated to stops by this means: Gln
(CAA, CAG), Trp (TGG), and Arg (only CGA). For Arg
five other codons exist for which this is not the case,
while all Gln and Trp codons can serve as substrates for
EMS-induced nonsense mutations. Thus the frequency
by which EMS causes premature chain terminations in a
gene is largely a function of the Gln and Trp content of
its product. It is interesting to note, therefore, that
dTAB2 has a Gln content that exceeds the mean Gln
frequency of the Drosophila proteome by more than a
factor of 2.5 (13.7% vs. 5.1%). Indeed, molecular
analysis of our dTAB2 alleles revealed that 24 of the 39
alleles are nonsense mutations of Gln codons (Figure
3C, red alleles).
The pathway: A central issue concerning the TNF/
JNK pathway relates to the question of how TAK1 is
activated (Shibuya et al. 1996; Kishimoto et al. 2000;
Sakurai et al. 2000). On the basis of previous studies
and our genetic and biochemical analysis we propose
a model for the Eiger pathway, in which dTAB2 and
dTRAF1 function as adaptors between the JNKKKK Msn
and the JNKKK dTAK1 and in this way may mediate
activation of dTAK1 by Msn and the subsequent trans-
duction of the signal via Hep and Bsk (Figure 6). The out-
line of the pathway is based on the following arguments:
1. Genetic studies have demonstrated the involvement
of Msn and dTAK1 in Eiger signaling (Igaki et al.
2002; Moreno et al. 2002).
2. We identified dTAB2 as an additional component of
the Eiger pathway (this article).
3. Epistasis experiments in S2 cells and in vivo place
Msn and dTAB2 upstream of dTAK1 and Hep (Figure
4, H–K).
4. Liu et al. (1999) have shown that Msn interacts with
dTRAF1.
5. dTAB2 also binds to dTRAF1 (Figure 5C). Although
we failed to detect biochemical evidence for a triple
complex Msn-dTRAF1-dTAB2 (data not shown),
points 4 and 5 suggest that dTRAF1 may act as an
adaptor to link Msn and dTAB2. It is possible that
such a complex forms only transiently and is thus
difficult to detect biochemically.
6. A triple complex consisting of dTRAF1-dTAB2-dTAK1
can form (Figure 5D), in which dTAB2 functions as a
link between dTRAF1 and dTAK1. While each of the
above arguments may also be compatible with other
models, they collectively support a scenario (Figure
6) in which dTAB2 facilitates the phosphorylation
of dTAK1 by Msn. The dominant-negative effect ob-
served by expression of wild-type dTAB2 is an indi-
cation that dTAB2 protein levels are critical for proper
complex formation (Figure 4E). Our observation
that the Eiger-induced small eye phenotype is not
entirely suppressed in animals homozygous mutant
for dTAB2 suggests that even in the absence of dTAB2
Msn is able to activate dTAK1, although only inef-
ficiently. In the wild-type situation, dTAB2 may func-
tion as an adaptor that stabilizes such a signaling
complex for efficient transduction of the Eiger signal.
Even though dTRAF1 exhibited a weaker interaction
than dTRAF2 toward dTAB2 and Wengen, we suggest
that dTRAF1 rather than dTRAF2 functions as a com-
ponent of this signaling complex on the basis of the
following arguments: (1) Only dTRAF1 but not dTRAF2
binds to Msn (Liu et al. 1999); (2) loss-of-function and
protein-interaction studies place dTRAF1 in the JNK
pathway and dTRAF2 in the NF-kB pathway (Liu et al.
1999; Shen et al. 2001; Cha et al. 2003); and (3) males
hemizygous mutant for dTRAF2 do not suppress the
Eiger-induced small eye phenotype (not shown; dTRAF1
alleles are homozygous lethal and could not be properly
analyzed—see materials and methods).
In mammalian systems it is not understood how TAK1
is activated. TAB1 is an activator of TAK1, but the
Figure 6.—Proposed model for Eiger signaling in Dro-
sophila. Following the binding of Eiger to Wengen a signaling
complex consisting of Msn-dTRAF1-dTAB2-dTAK1 is stabi-
lized, which allows the phosphorylation and activation of dTAK1
by Msn. Subsequently dTAK1 activates the core JNKK-JNK
module, consisting of the Drosophila homologs Hep and Bsk.
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mechanism by which it activates TAK1 and the possible
involvement of upstream kinases are not known (Shibuya
et al. 1996; Sakurai et al. 2000). In Drosophila no
functional TAB1 homolog has been identified so far. On
the basis of our genetic epistasis data, its interaction with
dTRAF1, and its homology to MAP4Ks, we propose that
Msn functions as an upstream kinase of dTAK1. In
mammals NIK and germinal center kinases are struc-
tural homologs of Msn. NIK has been demonstrated to
act downstream of TAK1 (Ninomiya-Tsuji et al. 1999) in
NF-kB activation. Several germinal center kinases have
been involved in TRAF-mediated activation of JNK
(Yuasa et al. 1998; Fu et al. 1999; Shi et al. 1999; Shi
and Kehrl 2003). It will be interesting to determine
whether one of them plays a role in TNF-induced acti-
vation of TAK1. The mapping of other suppressor muta-
tions and the characterization of their corresponding
gene products may unravel important aspects of this
evolutionarily ancient signaling pathway that has been
employed for prominent roles in mammalian develop-
ment and homeostasis.
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